DANIELS LESLIE B
SEC Form 4 insider trading activity
DANIELS LESLIE B has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Sep 11, 2026.
On the most recent filing, DANIELS LESLIE B is listed as Director at Anterix Inc. Inside the rolling window, DANIELS LESLIE B reported no open-market purchases and 3 open-market sales totaling $1.1M in ATEX. The largest disclosed transaction in the window is a sale of 6,000 ATEX shares on Sep 3, 2026, worth $523K.
Companies traded
Other insiders at ATEX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.1M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has DANIELS LESLIE B made?
DANIELS LESLIE B has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company since 2026.
Which companies does DANIELS LESLIE B trade?
DANIELS LESLIE B has filed SEC Form 4 disclosures for 1 company, including ATEX.
When was DANIELS LESLIE B's most recent SEC Form 4 filing?
DANIELS LESLIE B's most recent SEC Form 4 filing on Tracefour is dated Sep 11, 2026.
What is DANIELS LESLIE B's total buy and sell value in the current window?
Inside the rolling retention window, DANIELS LESLIE B bought $0 and sold $1.1M based on SEC Form 4 filings.
What was DANIELS LESLIE B's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 6,000 ATEX shares on 2026-09-03, worth $523K, per SEC Form 4 filings.